New study reveals more than 1/3 of early-phase clinical trial participants reported Financial Toxicity – ACS Journal Cancer

ACS Journal Cancer shared a post on X about a recent paper by Sienna Durbin et al. published in Cancer.

“New study led by Sienna Durbin et al reveals more than 1/3 of early-phase clinical trial participants reported Financial Toxicity. Patients with financial toxicity reported lower QOL and acceptance, and increased self blame.”

Anh Lam, Resident at OU Health, shared this post, adding;

“So excited for Sienna Durbin et al for publishing this work and very grateful to work with her and be a part of this phenomenal team!!”

“Financial toxicity in early-phase cancer clinical trial participants”

Authors: Sienna Durbin, Debra Lundquist, Andrea Pelletier, Dejan Juric, Ryan Nipp et al.

Sienna Marie Durbin, M.D., is a Clinical Fellow in Medicine at Dana-Farber Cancer Institute, specializing in inpatient oncology. She is involved in the Hematology/Oncology department, focusing on providing comprehensive care for patients undergoing treatment for various types of cancer.